Decreased Jun-D and myogenin expression in muscle wasting of human cachexia - Test2 - elhamkhani - TriplyDB

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

http://www.wikidata.org/entity/Q24654557

about

Role of Inflammation in Muscle Homeostasis and Myogenesis Skeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humans The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.Molecular and cellular mechanisms of skeletal muscle atrophy: an update.Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.C/EBPβ-Thr217 Phosphorylation Stimulates Macrophage Inflammasome Activation and Liver Injury.Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.l-carnitine and cancer cachexia: Clinical and experimental aspects.Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.Novel investigational drugs mimicking exercise for the treatment of cachexia.Skeletal muscle regeneration in cancer cachexia.USP19-deubiquitinating enzyme regulates levels of major myofibrillar proteins in L6 muscle cells.Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.Doxorubicin chemotherapy affects intracellular and interstitial nitric oxide concentrations in skeletal muscle : Effect of doxorubicin on intracellular and interstitial NO in skeletal muscle.An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure.Molecular characterization of argininosuccinate synthase and argininosuccinate lyase from the liver of the African lungfish Protopterus annectens, and their mRNA expression levels in the liver, kidney, brain and skeletal muscle during aestivation.Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.

P2860

Q26778322-65C21351-10ED-4B39-B072-58BE34D512E4 Q27026517-CFC5B6E1-4923-480C-82E9-67227D09BD9A Q28078802-50E561AB-4CC8-4EDE-A826-256DEEC065EF Q30275433-9C035C78-E2A7-46E3-97C3-D21EAB9968B9 Q31037047-6217774E-9B33-492D-B462-930C8BF0D685 Q33737527-3E46E072-78A6-4E25-A710-AD4A6FCDE392 Q35120883-B23CB450-CCF3-4329-B428-EDF2808BDBCA Q35122201-EA3E4A8B-D244-4C7E-B089-BE06CF38C167 Q35254722-68B1FE0A-FC8B-436B-9100-41C6E9AEF017 Q36179105-F07C858B-EEE9-400B-B9C2-40B766B6ACAE Q36787452-35766DA2-6DC2-4678-961B-ACACB0D95515 Q36789815-2158ED7F-B0F5-4BD1-B940-B4931A707BF7 Q37042189-8F12400F-26A1-480D-A949-8ACCD138905C Q37863019-131E3C21-4FEB-4D6E-839A-1AED68515AEE Q38290238-B0F175DD-D5A3-4DC3-9A52-87242C135846 Q38631222-B399E488-DAB0-4794-B856-6501CC6A1A33 Q38726702-AD765741-8FD2-4A5B-83B2-6662CB84FB4A Q39796329-6568844A-8439-457E-A01A-FEF6B072CE70 Q42011965-87F9322E-AD51-44AF-8270-EC4BBD2AD102 Q44863433-B5BA42AE-2ED1-435B-81CA-AB6FED3BF27E Q46032685-A97BAEC4-2D85-4A8C-9E88-AC05347E5808 Q47992664-B7665D47-10E5-4533-A335-92CF7462358E Q55002120-0CFEE3B3-8BB0-487D-A0C3-F87B81F0B0DD Q55653938-ECAD648A-8FB1-4653-AC5B-3B43BC2799F4

P2860

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

http://www.wikidata.org/entity/Q24654557

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@ast

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@en

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@nl

type

label

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@ast

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@en

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@nl

prefLabel

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@ast

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@en

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@nl

P1433

Q24654557-473E5174-7E17-431B-B1D7-99B7C0AAD8C4

P1476

Q24654557-8014CE34-9A2F-46FA-A035-D5B2EB88E9C6

P2093

Q24654557-420E6C10-1E5D-4DC1-9E3E-BEB57EF24899

Q24654557-5BC8F9CA-8AF5-4664-AEF3-B9C3A74ACD0E

Q24654557-D3127EBA-D607-4D20-9046-521E511DB948

P2860

Q24654557-148EA6F6-8FCE-4153-998C-C2197DD68D07

Q24654557-153029BB-8085-4F54-B786-19FECF8AA25E

Q24654557-1CDE6C7A-C5AE-4788-B42C-611653F38CF5

Q24654557-2F8AB192-3F8F-4B9C-887B-B2D2CB4A0CF0

Q24654557-30001B0E-AD63-404A-8DA5-E030E8F896F5

Q24654557-362F3C26-3604-441B-AC96-9C39E375AD86

Q24654557-377B787E-B6E1-498A-A9C5-2A2185A14169

Q24654557-38FE3C62-5BA9-4483-A5AC-B7B250B7BDB6

Q24654557-39986EF1-7EA1-49B3-93C8-5E4204B19F35

Q24654557-39E20ADF-5A31-4D6F-A803-F1AE9F455B0C

P304

Q24654557-F9040FEB-BDA7-4CA2-BD6E-1156E003C2E0

P31

Q24654557-0BC747DB-B50F-4E7E-A264-0F287E5322DF

P3181

Q24654557-0FB64375-4089-4E6A-8C93-C3D043B34F71

P356

Q24654557-DDAC57EF-ACED-4899-B6AE-5F85B2750FC5

P407

Q24654557-F634441C-A1F3-44C1-ABE8-AA467E07CBEC

P433

Q24654557-5CF8E491-081A-41BC-B168-718F66134C00

P478

Q24654557-03DA9F8B-0718-45D5-86DD-BF02FEBDDF6A

P577

Q24654557-AC4C4584-8536-4FDC-B26B-0698F8626686

P698

Q24654557-6F92652E-453B-4B25-A24F-4508ED136B67

P932

Q24654557-F51D690B-0E32-4485-824A-2925AF43F603

P3181

P356

AJPENDO.90529.2008

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

@en

P2093

Martina Buck

http://www.w3.org/2001/XMLSchema#string

Michael Donohue

http://www.w3.org/2001/XMLSchema#string

Sonia Ramamoorthy

http://www.w3.org/2001/XMLSchema#string

P2860

Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis

Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha

Characterization of a cancer cachectic factor

Random-effects models for longitudinal data

Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia

P304

E392-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2371246

http://www.w3.org/2001/XMLSchema#string

P356

10.1152/AJPENDO.90529.2008

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19470832

http://www.w3.org/2001/XMLSchema#string

P932

2724118

http://www.w3.org/2001/XMLSchema#string